Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients.

Authors	J Klehmet, C Meisel, A Meisel
Journal	Clinical and experimental immunology (Clin Exp Immunol) Vol. 178 Suppl 1 Pg. 149-50 (Dec 2014) ISSN: 1365-2249 [Electronic] England
PMID	25546800 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Immunoglobulins, Intravenous Myelin P2 Protein Myelin Proteins PMP22 protein, human Interferon-gamma
Topics	CD4-Positive T-Lymphocytes (immunology) CD8-Positive T-Lymphocytes (immunology) Case-Control Studies Humans Immunoglobulins, Intravenous (administration & dosage, immunology) Interferon-gamma (immunology) Monocytes (immunology) Myelin P2 Protein (immunology) Myelin Proteins (immunology) Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!